Vnus Medical names new chief medical officer
Prior to joining Vnus, Dr Smeets served as the head of clinical affairs for Pelikan Technologies, a privately held diagnostic testing platform company. Dr Smeets holds a doctor
Tolerance Bio has signed an agreement securing an exclusive licence from Tanabe Pharma for TLB-33, a clinical-stage anti-IL-33 monoclonal antibody, in a deal that includes potential development and sales milestone payments of up to around $560m.